EU research consortium CATCH ME



Characterizing Atrial fibrillation by Translating its Causes into Health Modifiers in the Elderly (CATCH ME)





CATCH ME aims to improve the prevention and treatment of atrial fibrillation and its complications. The goal is to develop and validate better disease management strategies based on the improved understanding of the main health modifiers (such as genes, drugs, and behaviour) leading to atrial fibrillation in the European population.

The CATCH ME partners combine excellence in clinical practice, translational pathophysiology, genetics, bioengineering, epidemiology and biostatistics with competence in the development of cardiovascular practice guidelines. As a consortium, CATCH ME also has access to large sets of human biological specimens (atrial tissue and blood samples) and carefully phenotyped patient populations. This is the basis to define the major causes and risk factors (“health modifiers”) of AF in Europe and characterise distinct clinical types of AF to advance future personalised strategies for prevention, diagnosis, and treatment of AF patients. AFNET will bring its competence in ethical issues as well as training programs and science communication in order to disseminate and popularize the results.


Zeemering S, Isaacs A, Winters J, Maesen B, Bidar E, Dimopoulou C, Guasch E, Batlle M, Haase D, Hatem S, Kara M, Kääb S, Mont L, Sinner M, Wakili R, Maessen J, Crijns HJGM, Fabritz L, Kirchhof P. Stoll M, Schotten S. Atrial fibrillation in the presence and absence of heart failure enhances expression of genes involved in cardomyocyte structure, conduction properties, fibrosis, inflammation, and endothelial dysfunction. HeartRhythm Journal, 21 August 2022. doi: 10.1016/j.hrthm.2022.08.019

Current status


Project start:


Project end:



CATCH ME Consortium

  • University of Birmingham, UK
  • Universidad de Barcelona, Spain
  • Maastricht University, The Netherlands
  • Ludwig-Maximilians University Munich und German Centre for Cardiovascular Research (DZHK), Germany
  • University of Oxford, UK
  • Université Pierre et Marie Curie, France
  • Atrial Fibrillation Network (AFNET), Germany
  • European Society of Cardiology (ESC), France


Coordinating Investigator

Prof. Dr. Paulus Kirchhof, Birmingham, UK



This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633196 (CATCH ME)


Associated Partners

Roche Professional Diagnostics, Switzerland




Atrial Fibrillation NETwork (AFNET)
Mendelstraße 11
48149 Münster, Germany

Phone: +49 251 980 1330
Fax: +49 251 980 1349
Email: info[at]